Related Experiment Video
Updated: Aug 15, 2026

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
Published on: July 17, 2020
The src homology 2 domain-containing tyrosine phosphatase 2 regulates primary T-dependent immune responses and Th
Robert J Salmond1, Gregory Huyer, Anastasia Kotsoni
1Laboratory of Lymphocyte Signalling and Development, The Babraham Institute, Babraham, Cambridge, United Kingdom. robert.salmond@bbsrc.ac.uk
Abstract:
The src homology 2 domain-containing tyrosine phosphatase 2 (SHP2) plays an important role in development and in growth factor receptor signaling pathways, yet little is known of its role in the immune system. We generated mice expressing a dominant-negative version of the protein, SHP2(CS), specifically in T cells. In SHP2(CS) mice, T cell development appears normal with regard to both negative and positive selection. However, SHP2(CS) T cells express higher levels of activation markers, and aged mice have elevated serum Abs. This is associated with a marked increase in IL-4, IL-5, and IL-10 secretion by SHP2(CS) T cells in vitro. In addition, primary thymus-dependent B cell responses are deficient in SHP2(CS) mice. We show that whereas TCR-induced linker for activation of T cells phosphorylation is defective, CTLA-4 and programmed death-1 signaling are not affected by SHP2(CS) expression. Our results suggest that a key action of wild-type SHP2 is to suppress differentiation of T cells to the Th2 phenotype.
Insights
Src homology 2 domain-containing tyrosine phosphatase 2 (SHP2) normally suppresses T cell differentiation into the Th2 phenotype. Inhibiting SHP2 in T cells increases activation markers and cytokine secretion, impairing B cell responses.
Area of Science:
- Immunology
- Molecular Biology
- Cell Signaling
Background:
- Src homology 2 domain-containing tyrosine phosphatase 2 (SHP2) is crucial for development and growth factor signaling.
- Its specific role within the immune system, particularly in T cells, remains largely uncharacterized.
Purpose of the Study:
- To investigate the function of SHP2 in T cell-mediated immunity.
- To elucidate the impact of dominant-negative SHP2 expression specifically within T cells on immune responses.
Main Methods:
- Generation of transgenic mice expressing a dominant-negative SHP2 (SHP2(CS)) specifically in T cells.
- Analysis of T cell development, activation markers, cytokine production (IL-4, IL-5, IL-10), and B cell responses in SHP2(CS) mice.
- Assessment of T cell receptor (TCR) and co-inhibitory receptor signaling pathways (CTLA-4, PD-1).
Main Results:
- T cell development (positive and negative selection) was normal in SHP2(CS) mice.
- SHP2(CS) T cells exhibited heightened activation markers and increased secretion of IL-4, IL-5, and IL-10 in vitro.
- Aged SHP2(CS) mice showed elevated serum antibody levels, but primary T-dependent B cell responses were impaired.
- TCR-induced Lck phosphorylation was defective, while CTLA-4 and PD-1 signaling remained unaffected.
Conclusions:
- Wild-type SHP2 plays a critical role in suppressing the differentiation of T cells towards the Th2 phenotype.
- SHP2 acts as a negative regulator of T cell activation and Th2 polarization, impacting adaptive immunity.
Related Concept Videos
Receptor Tyrosine Kinases
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
TGF - β Signaling Pathway
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...

